These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28822689)

  • 1. Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.
    Muthuramu I; Amin R; Postnov A; Mishra M; Aboumsallem JP; Dresselaers T; Himmelreich U; Van Veldhoven PP; Gheysens O; Jacobs F; De Geest B
    Mol Ther; 2017 Nov; 25(11):2513-2525. PubMed ID: 28822689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol lowering attenuates pressure overload-induced heart failure in mice with mild hypercholesterolemia.
    Muthuramu I; Mishra M; Aboumsallem JP; Postnov A; Gheysens O; De Geest B
    Aging (Albany NY); 2019 Sep; 11(17):6872-6891. PubMed ID: 31484164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload.
    Amin R; Muthuramu I; Aboumsallem JP; Mishra M; Jacobs F; De Geest B
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective homocysteine-lowering gene transfer attenuates pressure overload-induced cardiomyopathy via reduced oxidative stress.
    Muthuramu I; Singh N; Amin R; Nefyodova E; Debasse M; Van Horenbeeck I; Jacobs F; De Geest B
    J Mol Med (Berl); 2015 Jun; 93(6):609-18. PubMed ID: 25860230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice.
    Aboumsallem JP; Muthuramu I; Mishra M; De Geest B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte-Specific SR-BI Gene Transfer Corrects Cardiac Dysfunction in Scarb1-Deficient Mice and Improves Pressure Overload-Induced Cardiomyopathy.
    Muthuramu I; Amin R; Aboumsallem JP; Mishra M; Robinson EL; De Geest B
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2028-2040. PubMed ID: 29976771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.
    Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ
    Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coconut Oil Aggravates Pressure Overload-Induced Cardiomyopathy without Inducing Obesity, Systemic Insulin Resistance, or Cardiac Steatosis.
    Muthuramu I; Amin R; Postnov A; Mishra M; Jacobs F; Gheysens O; Van Veldhoven PP; De Geest B
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia.
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):28-38. PubMed ID: 28319445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy.
    Kolwicz SC; Olson DP; Marney LC; Garcia-Menendez L; Synovec RE; Tian R
    Circ Res; 2012 Aug; 111(6):728-38. PubMed ID: 22730442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):39-50. PubMed ID: 28319449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS; Martins I; Davidson BL
    J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of AAV8 vectors expressing human low-density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemia.
    Chen SJ; Sanmiguel J; Lock M; McMenamin D; Draper C; Limberis MP; Kassim SH; Somanathan S; Bell P; Johnston JC; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):154-60. PubMed ID: 24070336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
    Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
    Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol.
    Khan JA; Cao M; Kang BY; Liu Y; Mehta JL; Hermonat PL
    Atherosclerosis; 2010 Nov; 213(1):59-66. PubMed ID: 20727521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Zhang P; Xu X; Hu X; van Deel ED; Zhu G; Chen Y
    Circ Res; 2007 Apr; 100(7):1089-98. PubMed ID: 17363700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway.
    Zhao D; Wang W; Wang H; Peng H; Liu X; Guo W; Su G; Zhao Z
    Int J Biol Sci; 2017; 13(3):276-285. PubMed ID: 28367092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.